Free Trial

Cushman & Wakefield (CWK) Financials

Cushman & Wakefield logo
$12.47 +0.03 (+0.27%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$12.44 -0.03 (-0.26%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cushman & Wakefield

Annual Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-434 -221 -186 0.20 -221 250 196 -35 131 88
Consolidated Net Income / (Loss)
-435 -221 -186 0.20 -221 250 196 -35 131 88
Net Income / (Loss) Continuing Operations
-435 -221 -186 0.20 -221 250 196 -35 131 88
Total Pre-Tax Income
-459 -342 -211 43 -177 340 338 -30 176 114
Total Revenue
-166 6,742 7,993 8,603 7,688 -158 9,998 9,271 9,254 9,904
Net Interest Income / (Expense)
-172 -183 -229 -151 -164 -180 -193 -281 -230 -216
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 -193 0.00 0.00 0.00
Total Interest Expense
172 183 229 151 164 180 0.00 281 230 216
Long-Term Debt Interest Expense
172 183 229 151 164 180 - 281 230 216
Total Non-Interest Income
5.90 6,925 8,222 8,754 7,852 21 10,191 9,552 9,484 10,120
Net Realized & Unrealized Capital Gains on Investments
5.90 1.40 1.90 2.60 8.30 21 85 58 37 -168
Other Non-Interest Income
- 6,924 8,220 8,751 7,844 - 10,106 9,494 9,447 10,288
Total Non-Interest Expense
295 7,095 8,207 8,564 7,865 -497 9,660 9,288 9,108 9,836
Other Operating Expenses
6,218 6,796 7,916 8,259 7,576 8,675 9,415 9,104 8,944 9,725
Depreciation Expense
261 271 290 297 264 172 147 146 122 104
Impairment Charge
32 29 1.50 7.70 57 45 8.90 38 41 6.10
Nonoperating Income / (Expense), net
2.40 11 3.50 3.50 - 1.20 - -13 29 46
Income Tax Expense
-24 -121 -25 43 44 90 142 5.40 45 26
Basic Earnings per Share
($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57 $0.38
Weighted Average Basic Shares Outstanding
141.40M 143.90M 171.20M 217.70M 220.80M 223M 225.40M 226.90M 228.90M 231.20M
Diluted Earnings per Share
($3.07) ($1.54) ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56 $0.38
Weighted Average Diluted Shares Outstanding
141.40M 143.90M 171.20M 224.50M 220.80M 226.50M 228M 226.90M 232.80M 234.70M
Weighted Average Basic & Diluted Shares Outstanding
141.40M 143.90M 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M 231.82M

Quarterly Income Statements for Cushman & Wakefield

This table shows Cushman & Wakefield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-34 70 -29 14 34 113 1.90 57 51 -22 -13
Consolidated Net Income / (Loss)
-34 70 -29 14 34 113 1.90 57 51 -22 -13
Net Income / (Loss) Continuing Operations
-34 70 -29 14 34 113 1.90 57 51 -22 -13
Total Pre-Tax Income
-17 70 -27 17 53 132 5.00 76 45 -12 -9.60
Total Revenue
2,213 2,512 2,138 2,232 2,301 2,583 2,243 2,431 2,541 2,688 2,483
Net Interest Income / (Expense)
-90 -57 -59 -61 -55 -56 -52 -53 -56 -55 -49
Total Interest Income
0.00 -281 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense
90 -224 59 61 55 56 52 53 56 55 49
Long-Term Debt Interest Expense
90 - 59 61 55 56 52 53 56 55 49
Total Non-Interest Income
2,303 2,569 2,197 2,292 2,356 2,639 2,296 2,484 2,597 2,743 2,532
Net Realized & Unrealized Capital Gains on Investments
17 17 12 4.30 12 9.30 11 0.20 -8.60 -171 -4.10
Other Non-Interest Income
2,286 2,552 2,185 2,288 2,344 2,630 2,285 2,484 2,606 2,914 2,536
Total Non-Interest Expense
2,228 2,444 2,166 2,218 2,269 2,481 2,239 2,361 2,498 2,737 2,477
Other Operating Expenses
2,183 2,391 2,129 2,169 2,226 2,421 2,206 2,335 2,473 2,712 2,452
Depreciation Expense
36 37 33 31 29 30 27 26 26 26 25
Impairment Charge
9.20 15 5.00 17 14 4.60 6.50 0.00 0.00 -0.40 0.00
Nonoperating Income / (Expense), net
-2.00 - 1.70 3.30 21 - 0.90 6.40 2.20 37 -15
Income Tax Expense
17 0.30 2.30 3.70 19 19 3.10 19 -6.30 10 3.00
Basic Earnings per Share
($0.15) $0.31 ($0.13) $0.06 $0.15 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05)
Weighted Average Basic Shares Outstanding
227.20M 226.90M 227.90M 229M 229.30M 228.90M 230.40M 231.40M 231.50M 231.20M 232.80M
Diluted Earnings per Share
($0.15) $0.31 ($0.13) $0.06 $0.14 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05)
Weighted Average Diluted Shares Outstanding
227.20M 226.90M 227.90M 231.50M 233.40M 232.80M 232.30M 232.40M 235.90M 234.70M 232.80M
Weighted Average Basic & Diluted Shares Outstanding
227.25M 227.33M 229.05M 229.25M 229.49M 229.73M 231.29M 231.53M 231.60M 231.82M 234.30M

Annual Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-116 29 506 -95 276 -266 -151 80 36 -31
Net Cash From Operating Activities
-335 4.40 -2.20 269 -38 550 49 152 208 340
Net Cash From Continuing Operating Activities
-335 4.40 -2.20 269 -38 550 49 152 208 340
Net Income / (Loss) Continuing Operations
-435 -221 -186 0.20 -221 250 196 -35 131 88
Consolidated Net Income / (Loss)
-435 -221 -186 0.20 -221 250 196 -35 131 88
Provision For Loan Losses
12 3.90 24 26 48 38 32 11 21 22
Depreciation Expense
261 271 290 297 264 172 147 146 122 104
Amortization Expense
13 17 13 122 128 114 112 105 94 95
Non-Cash Adjustments to Reconcile Net Income
38 42 138 49 -25 68 87 101 6.40 187
Changes in Operating Assets and Liabilities, net
-224 -107 -280 -226 -233 -92 -524 -175 -167 -156
Net Cash From Investing Activities
-138 -143 -218 -275 -258 -750 -121 49 81 -21
Net Cash From Continuing Investing Activities
-138 -143 -218 -275 -258 -750 -121 49 81 -21
Purchase of Property, Leasehold Improvements and Equipment
-77 -129 -84 -80 -41 -54 -51 -51 -41 -47
Purchase of Investment Securities
-57 -100 -49 -280 -123 -696 -139 -0.10 -0.40 -5.20
Sale and/or Maturity of Investments
3.80 86 -85 86 -94 0.20 69 100 123 32
Net Cash From Financing Activities
357 168 726 -90 572 -66 -79 -121 -253 -351
Net Cash From Continuing Financing Activities
357 168 726 -90 572 -66 -79 -121 -253 -351
Issuance of Debt
640 319 2,937 0.00 650 0.00 0.00 2,400 0.00 0.00
Repayment of Debt
-320 -164 -3,168 -39 -43 -40 -44 -2,470 -200 -300
Other Financing Activities, Net
-2.90 -11 -62 -51 -35 -26 -35 -51 -53 -51

Quarterly Cash Flow Statements for Cushman & Wakefield

This table details how cash moves in and out of Cushman & Wakefield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
71 157 -209 22 197 26 -183 -16 20 148 -178
Net Cash From Operating Activities
188 202 -125 22 196 115 -162 9.60 236 257 -244
Net Cash From Continuing Operating Activities
188 202 -125 22 196 115 -162 9.60 236 257 -244
Net Income / (Loss) Continuing Operations
-34 70 -29 14 34 113 1.90 57 51 -22 -13
Consolidated Net Income / (Loss)
-34 70 -29 14 34 113 1.90 57 51 -22 -13
Provision For Loan Losses
3.00 5.80 2.40 5.30 3.00 10 2.80 -0.20 5.50 14 4.80
Depreciation Expense
36 37 33 31 29 30 27 26 26 26 25
Amortization Expense
25 28 24 26 24 21 24 24 23 24 24
Non-Cash Adjustments to Reconcile Net Income
23 26 -6.80 9.50 -12 16 3.90 8.60 22 153 55
Changes in Operating Assets and Liabilities, net
135 36 -148 -63 118 -74 -221 -106 108 64 -341
Net Cash From Investing Activities
-65 -31 -11 68 57 -33 21 11 -60 7.90 94
Net Cash From Continuing Investing Activities
-65 -31 -11 68 57 -33 21 11 -60 7.90 94
Purchase of Property, Leasehold Improvements and Equipment
-14 -16 -11 -12 -9.40 -9.30 -4.60 -9.30 -11 -23 -12
Purchase of Investment Securities
41 4.90 -0.30 100 0.40 -506 -12 -0.20 -388 388 -1.10
Sale and/or Maturity of Investments
-92 -20 0.00 -20 -55 481 37 20 339 -357 107
Net Cash From Financing Activities
-52 -14 -73 -68 -57 -56 -41 -36 -156 -117 -28
Net Cash From Continuing Financing Activities
-52 -14 -73 -68 -57 -56 -41 -36 -156 -117 -28
Repayment of Debt
-1,431 -2.20 -55 -38 -50 -79 -25 -25 -170 -80 0.00
Other Financing Activities, Net
-21 -12 -18 -30 -7.00 23 -16 -11 14 -37 -28

Annual Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549 7,677
Cash and Due from Banks
406 895 813 1,075 771 645 768 793 784
Trading Account Securities
7.90 8.70 7.90 115 641 677 708 724 537
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
304 314 299 236 195 173 164 136 133
Goodwill
1,765 1,779 1,969 2,098 2,082 2,066 2,081 1,998 2,058
Intangible Assets
1,306 1,128 1,063 991 922 875 806 690 655
Other Assets
2,004 2,422 3,011 2,823 3,280 3,515 3,248 3,208 3,510
Total Liabilities & Shareholders' Equity
5,793 6,546 7,163 7,338 7,890 7,949 7,774 7,549 7,677
Total Liabilities
5,294 5,186 5,862 6,242 6,442 6,287 6,096 5,794 5,721
Short-Term Debt
60 40 39 40 42 50 150 103 125
Accrued Interest Payable
36 43 60 45 105 33 21 20 29
Other Short-Term Payables
1,870 1,956 2,224 1,981 2,287 2,308 2,227 2,207 2,438
Long-Term Debt
2,784 2,644 2,620 3,236 3,221 3,212 3,097 2,940 2,625
Other Long-Term Liabilities
544 503 919 941 787 685 602 524 504
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
499 1,360 1,301 1,096 1,449 1,662 1,678 1,755 1,956
Total Preferred & Common Equity
499 1,360 1,301 1,095 1,448 1,661 1,677 1,755 1,955
Total Common Equity
499 1,360 1,301 1,095 1,448 1,661 1,677 1,755 1,955
Common Stock
1,735 2,813 2,819 2,866 2,919 2,934 2,980 3,009 3,062
Retained Earnings
-1,149 -1,298 -1,297 -1,528 -1,278 -1,082 -1,117 -986 -898
Accumulated Other Comprehensive Income / (Loss)
-87 -154 -243 -243 -193 -191 -185 -269 -209
Noncontrolling Interest
- - 0.00 0.90 0.80 0.80 0.60 0.50 0.50

Quarterly Balance Sheets for Cushman & Wakefield

This table presents Cushman & Wakefield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
7,622 7,622 7,640 7,582 7,491 7,343 7,534 7,408 7,555 7,691 7,648
Cash and Due from Banks
381 460 502 588 554 567 775 623 618 634 601
Trading Account Securities
659 686 682 694 714 711 724 735 732 720 529
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
156 170 166 160 155 148 142 126 124 122 134
Goodwill
2,021 2,067 2,073 2,052 2,064 2,024 2,049 2,021 2,060 2,055 2,059
Intangible Assets
885 858 841 823 791 712 703 682 675 664 645
Other Assets
3,519 3,382 3,376 3,265 3,213 3,181 3,141 3,220 3,347 3,496 3,680
Total Liabilities & Shareholders' Equity
7,622 7,622 7,640 7,582 7,491 7,343 7,534 7,408 7,555 7,691 7,648
Total Liabilities
6,044 6,042 6,018 6,011 5,866 5,704 5,831 5,631 5,651 5,733 5,695
Short-Term Debt
46 34 37 119 125 142 96 109 175 129 130
Accrued Interest Payable
27 6.90 55 7.00 20 28 31 31 64 75 87
Other Short-Term Payables
2,150 2,080 2,031 2,091 2,035 1,966 2,114 2,063 2,087 2,302 2,210
Long-Term Debt
3,212 3,228 3,226 3,125 3,066 3,002 2,997 2,911 2,820 2,720 2,621
Other Long-Term Liabilities
609 694 668 669 620 567 593 517 505 507 648
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,578 1,580 1,622 1,572 1,625 1,640 1,703 1,777 1,904 1,958 1,953
Total Preferred & Common Equity
1,577 1,579 1,621 1,571 1,625 1,639 1,702 1,776 1,904 1,958 1,952
Total Common Equity
1,577 1,579 1,621 1,571 1,625 1,639 1,702 1,776 1,904 1,958 1,952
Common Stock
2,924 2,939 2,953 2,967 2,978 2,982 2,994 3,015 3,029 3,044 3,057
Retained Earnings
-1,112 -1,158 -1,153 -1,187 -1,146 -1,133 -1,099 -984 -927 -875 -910
Accumulated Other Comprehensive Income / (Loss)
-235 -202 -178 -209 -207 -211 -192 -255 -199 -211 -194
Noncontrolling Interest
0.70 0.50 0.60 0.50 0.60 0.60 0.60 0.50 0.60 0.50 0.40

Annual Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - -
Profitability Metrics
- - - - - - - - - -
Valuation Ratios
- - - - - - - - - -
Leverage & Solvency
- - - - - - - - - -
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Efficiency Ratios
- - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - -
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $1.12 $0.87 ($0.16) $0.57 $0.38
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 216.60M 219.89M 222.18M 223M 225.40M 226.90M 228.90M 231.20M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $1.10 $0.86 ($0.16) $0.56 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 216.60M 224.50M 220.80M 226.50M 228M 226.90M 232.80M 234.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($1.09) $0.00 ($1.00) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 171.20M 217.70M 220.80M 224.55M 225.80M 227.33M 229.73M 231.82M
Debt Service Ratios
- - - - - - - - - -
Payout Ratios
- - - - - - - - - -

Quarterly Metrics And Ratios for Cushman & Wakefield

This table displays calculated financial ratios and metrics derived from Cushman & Wakefield's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 231,821,697.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 231,821,697.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7,379.93% -67.59% -2.13% -5.48% 3.99% 2.83% 4.94% 8.94% 10.42% - 10.66%
EBITDA Growth
-67.33% 102.44% 215.23% 9.14% 131.37% 15.14% 96.04% 69.31% 7.36% - 0.73%
EBIT Growth
-118.73% 9,828.57% 70.29% 168.75% 446.41% 50.81% 114.54% 402.16% 32.41% - 31.71%
NOPAT Growth
-127.48% 134.23% 70.29% 164.71% 414.66% 61.75% 107.89% 381.10% 137.33% - 142.62%
Net Income Growth
-241.84% 134.23% 62.30% 164.71% 199.41% 61.75% 106.60% 324.44% 52.52% - -763.16%
EPS Growth
-236.36% 158.33% 61.76% 200.00% 193.33% 58.06% 107.69% 316.67% 57.14% - -600.00%
Operating Cash Flow Growth
263.83% -16.95% 43.52% 229.76% 4.25% -43.08% -29.50% -55.96% 20.09% - -50.31%
Free Cash Flow Firm Growth
103.27% 137.74% 105.99% 413.55% 445.92% 247.82% 325.54% -156.50% -4.54% - 338.02%
Invested Capital Growth
-0.42% 0.02% -0.51% -2.09% -0.40% -2.57% -0.42% 2.43% 0.23% - -1.93%
Revenue Q/Q Growth
-6.26% 13.52% -55.45% 4.38% 3.13% 12.25% -13.16% 8.36% 4.54% - -7.65%
EBITDA Q/Q Growth
-32.30% 189.32% -77.79% 150.85% 43.51% 43.97% -64.36% 119.63% -23.22% - 9,050.00%
EBIT Q/Q Growth
-339.06% 545.10% -138.91% 164.91% 208.14% 93.77% -96.01% 1,602.44% -38.54% - 111.07%
NOPAT Q/Q Growth
-310.00% 751.73% -126.58% 172.78% 149.63% 235.01% -98.62% 3,268.90% -6.85% - 111.07%
Net Income Q/Q Growth
-764.71% 305.90% -141.26% 146.88% 149.63% 235.01% -98.32% 2,915.79% -10.30% - 43.75%
EPS Q/Q Growth
-850.00% 306.67% -141.94% 146.15% 133.33% 250.00% -97.96% 2,400.00% -12.00% - 50.00%
Operating Cash Flow Q/Q Growth
1,219.64% 7.60% -161.81% 117.43% 799.54% -41.25% -240.63% 105.93% 2,353.13% - -194.64%
Free Cash Flow Firm Q/Q Growth
126.26% 610.01% -90.77% 1,722.05% -54.28% 352.36% -90.82% -391.07% 159.44% - 64.58%
Invested Capital Q/Q Growth
-1.42% 2.26% -2.20% -0.69% 0.28% 0.04% -0.05% 2.16% -1.88% - -0.04%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
2.07% 5.29% 1.38% 3.32% 4.61% 5.92% 2.43% 4.92% 3.62% - 2.21%
EBIT Margin
-0.69% 2.71% -1.24% 0.77% 2.30% 3.98% 0.18% 2.87% 1.69% - 0.22%
Profit (Net Income) Margin
-1.53% 2.78% -1.35% 0.61% 1.46% 4.37% 0.08% 2.36% 2.02% - -0.51%
Tax Burden Percent
195.95% 99.57% 108.68% 78.49% 63.58% 85.47% 38.00% 75.20% 113.97% - 131.25%
Interest Burden Percent
113.07% 102.94% 100.00% 100.00% 100.00% 128.63% 121.95% 109.17% 105.13% - -177.78%
Effective Tax Rate
0.00% 0.43% 0.00% 21.51% 36.42% 14.53% 62.00% 24.80% -13.97% - 0.00%
Return on Invested Capital (ROIC)
-1.46% 5.23% -1.66% 1.14% 2.80% 8.32% 0.14% 4.26% 3.93% - 0.33%
ROIC Less NNEP Spread (ROIC-NNEP)
-2.17% 5.23% -1.98% 1.14% 2.80% 8.32% 0.15% 4.42% 4.01% - -0.24%
Return on Net Nonoperating Assets (RNNOA)
-4.48% 10.19% -3.98% 2.24% 5.42% 15.24% 0.27% 7.66% 6.51% - -0.38%
Return on Equity (ROE)
-5.93% 15.42% -5.63% 3.37% 8.21% 23.56% 0.40% 11.92% 10.44% - -0.05%
Cash Return on Invested Capital (CROIC)
0.26% -0.45% 0.77% 2.54% 2.23% 4.85% 3.33% 1.34% 4.19% - 3.03%
Operating Return on Assets (OROA)
-1.32% 3.20% -1.51% 0.94% 2.80% 4.80% 0.23% 3.68% 2.17% - 0.29%
Return on Assets (ROA)
-2.92% 3.28% -1.64% 0.73% 1.78% 5.28% 0.11% 3.02% 2.60% - -0.68%
Return on Common Equity (ROCE)
-5.93% 15.42% -5.63% 3.37% 8.21% 23.55% 0.40% 11.92% 10.43% - -0.05%
Return on Equity Simple (ROE_SIMPLE)
-4.80% 0.00% 0.75% 1.26% 5.18% 0.00% 9.12% 10.81% 11.42% - 3.78%
Net Operating Profit after Tax (NOPAT)
-11 70 -19 14 34 113 1.56 52 49 - 3.78
NOPAT Margin
-0.48% 2.78% -0.87% 0.61% 1.46% 4.37% 0.07% 2.16% 1.92% - 0.15%
Net Nonoperating Expense Percent (NNEP)
0.71% 0.00% 0.32% 0.00% 0.00% 0.00% -0.01% -0.16% -0.08% - 0.57%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue
100.69% 97.29% 101.24% 99.23% 97.70% 96.02% 99.82% 97.13% 98.31% - 99.78%
Earnings before Interest and Taxes (EBIT)
-15 68 -27 17 53 103 4.10 70 43 - 5.40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
46 133 30 74 106 153 55 120 92 - 55
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.10 1.46 1.46 1.45 1.84 1.71 1.32 1.35 1.88 - 1.46
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)
0.12 0.26 0.26 0.26 0.34 0.32 0.25 0.27 0.38 - 0.28
Price to Earnings (P/E)
0.00 0.00 194.84 115.64 35.43 22.86 14.49 12.44 16.49 - 38.56
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.51% 0.86% 2.82% 4.37% 6.90% 8.04% 6.06% - 2.59%
Enterprise Value to Invested Capital (EV/IC)
0.91 1.00 1.04 1.04 1.13 1.09 0.99 1.01 1.23 - 1.06
Enterprise Value to Revenue (EV/Rev)
0.30 0.53 0.54 0.55 0.59 0.57 0.51 0.52 0.60 - 0.49
Enterprise Value to EBITDA (EV/EBITDA)
18.08 22.34 18.17 17.57 15.89 14.48 12.19 11.27 13.27 - 18.69
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 153.37 114.00 48.69 35.87 26.55 21.05 24.08 - 72.05
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 411.07 240.72 61.72 48.03 33.97 27.24 27.84 - 97.36
Enterprise Value to Operating Cash Flow (EV/OCF)
22.67 32.42 20.17 17.27 18.44 25.25 27.73 31.08 29.76 - 19.28
Enterprise Value to Free Cash Flow (EV/FCFF)
351.26 0.00 135.18 40.38 50.68 22.28 29.64 76.08 29.35 - 34.75
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.06 1.93 1.96 1.92 1.82 1.73 1.70 1.57 1.46 - 1.41
Long-Term Debt to Equity
1.99 1.85 1.89 1.83 1.76 1.67 1.64 1.48 1.39 - 1.34
Financial Leverage
2.06 1.95 2.01 1.96 1.94 1.83 1.83 1.73 1.62 - 1.55
Leverage Ratio
4.83 4.71 4.72 4.59 4.62 4.46 4.38 4.20 4.16 - 4.04
Compound Leverage Factor
5.46 4.85 4.72 4.59 4.62 5.74 5.34 4.59 4.37 - -7.18
Debt to Total Capital
67.37% 65.93% 66.25% 65.72% 64.49% 63.42% 62.95% 61.14% 59.27% - 58.48%
Short-Term Debt to Total Capital
2.47% 3.04% 2.60% 2.96% 2.01% 2.15% 2.26% 3.57% 2.69% - 2.76%
Long-Term Debt to Total Capital
64.90% 62.89% 63.66% 62.76% 62.48% 61.26% 60.69% 57.57% 56.58% - 55.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% - 0.01%
Common Equity to Total Capital
32.62% 34.06% 33.74% 34.27% 35.49% 36.57% 37.04% 38.85% 40.72% - 41.51%
Debt to EBITDA
13.37 14.70 11.56 11.14 9.03 8.39 7.75 6.83 6.41 - 10.30
Net Debt to EBITDA
10.94 11.22 9.56 9.13 6.77 6.20 6.15 5.42 4.98 - 8.05
Long-Term Debt to EBITDA
12.88 14.02 11.11 10.64 8.75 8.11 7.48 6.43 6.12 - 9.81
Debt to NOPAT
-410.13 -154.60 261.55 152.59 35.07 27.83 21.62 16.52 13.44 - 53.64
Net Debt to NOPAT
-335.76 -118.04 216.18 125.05 26.28 20.57 17.16 13.11 10.45 - 41.93
Long-Term Debt to NOPAT
-395.09 -147.47 251.30 145.71 33.98 26.88 20.84 15.56 12.83 - 51.11
Noncontrolling Interest Sharing Ratio
0.04% 0.04% 0.03% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% - 0.02%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
9.69 69 6.35 116 53 239 22 -64 38 - 96
Operating Cash Flow to CapEx
1,324.65% 1,249.38% -1,191.43% 184.75% 2,086.17% 1,238.71% -3,521.74% 103.23% 2,242.86% - -1,995.90%
Free Cash Flow to Firm to Interest Expense
0.11 0.00 0.11 1.90 0.96 4.31 0.42 -1.20 0.68 - 1.95
Operating Cash Flow to Interest Expense
2.10 0.00 -2.13 0.36 3.57 2.08 -3.10 0.18 4.21 - -4.95
Operating Cash Flow Less CapEx to Interest Expense
1.94 0.00 -2.31 0.16 3.40 1.91 -3.19 0.01 4.02 - -5.20
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.91 1.18 1.22 1.21 1.22 1.21 1.26 1.28 1.29 - 1.35
Fixed Asset Turnover
91.72 55.12 56.80 57.89 60.83 61.73 66.59 70.29 74.49 - 77.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,816 4,925 4,816 4,783 4,796 4,798 4,796 4,899 4,807 - 4,704
Invested Capital Turnover
3.01 1.88 1.91 1.88 1.91 1.90 1.95 1.97 2.04 - 2.14
Increase / (Decrease) in Invested Capital
-20 1.00 -25 -102 -19 -126 -20 116 11 - -92
Enterprise Value (EV)
4,387 4,934 5,015 4,959 5,443 5,252 4,744 4,938 5,901 - 4,993
Market Capitalization
1,731 2,454 2,377 2,382 3,125 3,002 2,348 2,560 3,686 - 2,842
Book Value per Share
$6.92 $7.38 $7.13 $7.16 $7.43 $7.65 $7.73 $8.23 $8.45 - $8.42
Tangible Book Value per Share
($5.74) ($5.32) ($5.40) ($4.79) ($4.58) ($4.07) ($4.03) ($3.59) ($3.29) - ($3.24)
Total Capital
4,816 4,925 4,816 4,783 4,796 4,798 4,796 4,899 4,807 - 4,704
Total Debt
3,244 3,247 3,191 3,143 3,093 3,043 3,019 2,995 2,849 - 2,751
Total Long-Term Debt
3,125 3,097 3,066 3,002 2,997 2,940 2,911 2,820 2,720 - 2,621
Net Debt
2,656 2,479 2,637 2,576 2,318 2,250 2,396 2,377 2,215 - 2,150
Capital Expenditures (CapEx)
14 16 11 12 9.40 9.30 4.60 9.30 11 - 12
Net Nonoperating Expense (NNE)
23 0.00 10 0.00 0.00 0.00 -0.34 -4.81 -2.51 - 16
Net Nonoperating Obligations (NNO)
3,244 3,247 3,191 3,143 3,093 3,043 3,019 2,995 2,849 - 2,751
Total Depreciation and Amortization (D&A)
61 65 56 57 53 50 50 50 49 - 50
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) $0.31 ($0.13) $0.06 $0.15 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
227.20M 226.90M 227.90M 229M 229.30M 228.90M 230.40M 231.40M 231.50M 231.20M 232.80M
Adjusted Diluted Earnings per Share
($0.15) $0.31 ($0.13) $0.06 $0.14 $0.49 $0.01 $0.25 $0.22 ($0.10) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
227.20M 226.90M 227.90M 231.50M 233.40M 232.80M 232.30M 232.40M 235.90M 234.70M 232.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
227.25M 227.33M 229.05M 229.25M 229.49M 229.73M 231.29M 231.53M 231.60M 231.82M 234.30M
Normalized Net Operating Profit after Tax (NOPAT)
-4.27 84 -16 25 30 117 7.42 52 30 - 3.78
Normalized NOPAT Margin
-0.19% 3.36% -0.76% 1.10% 1.28% 4.52% 0.33% 2.16% 1.18% - 0.15%
Pre Tax Income Margin
-0.78% 2.79% -1.24% 0.77% 2.30% 5.11% 0.22% 3.13% 1.77% - -0.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.17 0.00 -0.45 0.28 0.97 1.85 0.08 1.31 0.77 - 0.11
NOPAT to Interest Expense
-0.12 0.00 -0.32 0.22 0.61 2.03 0.03 0.99 0.87 - 0.08
EBIT Less CapEx to Interest Expense
-0.33 0.00 -0.63 0.09 0.79 1.68 -0.01 1.14 0.58 - -0.14
NOPAT Less CapEx to Interest Expense
-0.28 0.00 -0.49 0.03 0.44 1.87 -0.06 0.81 0.69 - -0.17
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Cushman & Wakefield (NYSE:CWK) showed a much weaker start to 2026, with profitability under pressure and operating cash flow turning sharply negative. In Q1 2026, the company reported a net loss of $12.6 million, compared with a profit of $51.4 million in Q3 2025 and $1.9 million in Q1 2025. More importantly, operating cash flow was negative $243.5 million, a significant deterioration from $235.5 million of positive operating cash flow in Q3 2025 and negative $162.0 million in Q1 2025.

The quarterly trend suggests a business that remains cyclical and capital-intensive, with earnings that can swing sharply from period to period. Revenue and expense levels were broadly similar in recent quarters, but Q1 2026 was hurt by a large $340.6 million negative change in operating assets and liabilities, which overwhelmed the company’s non-cash earnings add-backs and pushed cash from operations deep into the red.

Balance sheet leverage remains a key watch item. At March 31, 2026, CWK had $2.62 billion of long-term debt and $129.8 million of short-term debt, against $1.95 billion of total common equity. That implies a leveraged capital structure, though the company also held a sizable cash and securities position.

Here are the most important takeaways for retail investors:

  • Cash and marketable securities remain substantial. CWK ended Q1 2026 with $600.6 million in cash and $529.2 million in trading account securities, giving it meaningful liquidity.
  • Investing cash flow was positive in Q1 2026. The company generated $94.1 million from investing activities, helped by $107.4 million in sales/maturities of investments.
  • Revenue remains large and relatively stable quarter to quarter. Q1 2026 total revenue was $2.48 billion, not far from $2.69 billion in Q4 2025 and $2.54 billion in Q3 2025.
  • Profitability improved sharply in late 2025 before fading again. The company earned $51.4 million in Q3 2025 and $112.9 million in Q4 2024, showing it can produce solid quarterly earnings in favorable periods.
  • Non-interest income is the dominant revenue driver. In Q1 2026, non-interest income was $2.53 billion versus interest expense of $49.2 million, so the business is highly reliant on fee-based and transactional income.
  • Depreciation and amortization remain consistent expense items. Q1 2026 depreciation was $25.3 million and amortization was $24.2 million, suggesting ongoing non-cash charges but not a major sudden shift.
  • Share count has been fairly steady. Weighted average diluted shares were 232.8 million in Q1 2026 versus 235.9 million in Q3 2025 and 231.4 million in Q2 2025.
  • Operating cash flow turned deeply negative in Q1 2026. Net cash from operating activities was negative $243.5 million, a major red flag for near-term cash generation.
  • Working capital outflow was the main drag on cash. Changes in operating assets and liabilities used $340.6 million of cash in Q1 2026, far worse than most recent quarters.
  • Debt burden remains elevated. Combined short- and long-term debt totaled about $2.75 billion at quarter-end, which limits flexibility if operating performance weakens further.

Bottom line: Cushman & Wakefield still has scale and liquidity, but the latest quarter showed a clear deterioration in cash generation and earnings. Investors should watch for stabilization in working capital, improvement in operating cash flow, and progress on debt reduction before getting more constructive on the stock.

06/01/26 05:27 AM ETAI Generated. May Contain Errors.

Cushman & Wakefield Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cushman & Wakefield's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Cushman & Wakefield's net income appears to be on a downward trend, with a most recent value of $88.20 million in 2025, falling from -$434.60 million in 2016. The previous period was $131.30 million in 2024. See Cushman & Wakefield's forecast for analyst expectations on what's next for the company.

Over the last 9 years, Cushman & Wakefield's total revenue changed from -$165.90 million in 2016 to $9.90 billion in 2025, a change of -6,069.7%.

Cushman & Wakefield's total liabilities were at $5.72 billion at the end of 2025, a 1.3% decrease from 2024, and a 8.1% increase since 2017.

In the past 8 years, Cushman & Wakefield's cash and equivalents has ranged from $405.60 million in 2017 to $1.07 billion in 2020, and is currently $784.20 million as of their latest financial filing in 2025.



Financial statements for NYSE:CWK last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners